Search research articles
Contact Us
Filters
Showing results (361-370 of 384) with videos related to
Page
of 39
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 13, 2025
Free energy and flexibility analysis of autoinhibited human BRAF
Jeremy O B Tempkin, Fikret Aydin, Sebnem Essiz, et al.
Journal of the American College of Cardiology
|
September 1, 2004
Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus
Meenakshi A Bhalla, Audrey Chiang, Victoria A Epshteyn, et al.
Journal of Natural Products
|
June 13, 2022
Tolypocladamides A-G: Cytotoxic Peptaibols from <i>Tolypocladium inflatum</i>
Sarath P D Senadeera, Dongdong Wang, Chang-Kwon Kim, et al.
Nature
|
November 3, 2025
Independent mechanisms of inflammation and myeloid bias in VEXAS syndrome
Varun K Narendra, Tandrila Das, Linsey J Wierciszewski, et al.
Aging Cell
|
February 17, 2023
Age-related changes to adipose tissue and peripheral neuropathy in genetically diverse HET3 mice differ by sex and are not mitigated by rapamycin longevity treatment
Jake W Willows, Morganne Robinson, Zahra Alshahal, et al.
Cancer Discovery
|
March 5, 2015
Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma
Tapan K Maity, Abhilash Venugopalan, Ilona Linnoila, et al.
Science Signaling
|
November 2, 2017
MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity
María-José Sandí, Christopher B Marshall, Marc Balan, et al.
Cytogenetic and Genome Research
|
June 26, 2004
Cloning and characterization of an inversion breakpoint at 6q23.3 suggests a role for Map7 in sacral dysgenesis
R Sood, P I Bader, M C Speer, et al.
Nature Communications
|
June 7, 2022
Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation
Brandon M Murphy, Elizabeth M Terrell, Venkat R Chirasani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2013
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer
B M Wolpin, E M O'Reilly, Y J Ko, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 384) with videos related to
Sort By:
Page
of 39
Biorxiv : the Preprint Server for Biology
|
August 13, 2025
Free energy and flexibility analysis of autoinhibited human BRAF
Jeremy O B Tempkin, Fikret Aydin, Sebnem Essiz, et al.
Journal of the American College of Cardiology
|
September 1, 2004
Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus
Meenakshi A Bhalla, Audrey Chiang, Victoria A Epshteyn, et al.
Journal of Natural Products
|
June 13, 2022
Tolypocladamides A-G: Cytotoxic Peptaibols from <i>Tolypocladium inflatum</i>
Sarath P D Senadeera, Dongdong Wang, Chang-Kwon Kim, et al.
Nature
|
November 3, 2025
Independent mechanisms of inflammation and myeloid bias in VEXAS syndrome
Varun K Narendra, Tandrila Das, Linsey J Wierciszewski, et al.
Aging Cell
|
February 17, 2023
Age-related changes to adipose tissue and peripheral neuropathy in genetically diverse HET3 mice differ by sex and are not mitigated by rapamycin longevity treatment
Jake W Willows, Morganne Robinson, Zahra Alshahal, et al.
Cancer Discovery
|
March 5, 2015
Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma
Tapan K Maity, Abhilash Venugopalan, Ilona Linnoila, et al.
Science Signaling
|
November 2, 2017
MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity
María-José Sandí, Christopher B Marshall, Marc Balan, et al.
Cytogenetic and Genome Research
|
June 26, 2004
Cloning and characterization of an inversion breakpoint at 6q23.3 suggests a role for Map7 in sacral dysgenesis
R Sood, P I Bader, M C Speer, et al.
Nature Communications
|
June 7, 2022
Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation
Brandon M Murphy, Elizabeth M Terrell, Venkat R Chirasani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2013
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer
B M Wolpin, E M O'Reilly, Y J Ko, et al.
Page
of 39